ADNT Adient
Adient earnings company data as of 11:02 AM ET 10/23
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 4 Nov | EPS | 0.66 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by ADNT's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $716K sold by 4 insiders outside a trading plan
- None no planned (10b5-1) sales
-
Peter Carlin DirectorSale$151K 7,843 shares at $19.25 17% of stakeTraded Sep 2 Filed Sep 4
-
Heather M Tiltmann EVP, CLO, CHRO & SecretarySale$500K 22,000 shares at $22.71 17% of stakeTraded Jun 4 Filed Jun 5
-
David Herberg EVP, EmeaSale$16K 699 shares at $22.58 1.7% of stakeTraded Jun 4 Filed Jun 5
-
Michel Pierre Rose Berthelin EVP, EmeaSale$49K 2,500 shares at $19.71 2.1% of stakeTraded Nov 26, 2025 Filed Nov 28, 2025
Also filed in the last 12 months, not counted as buying or selling: 26 share withholdings for taxes, 23 stock grants, 4 sales back to the company, and 4 option exercises.
SEC filings
Recent issuer filings from EDGAR, 19 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 5.02,9.01 | Filing Doc | |
| 8-K | 1.01,2.03 | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 5.02 | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 5.02,5.07 | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| 8-K | 1.01,2.03,9.01 | Filing Doc | |
| 10-K | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.